Coronavirus: Five New Cases of Thrombosis Linked to AstraZeneca Vaccine in France, Without Death

General News
Five new thrombosis cases linked to AstraZeneca Covid-19 Vaccine in France

HEALTH: According to French and European health authorities, the benefits of the AstraZeneca Vaccine continue to far outweigh the very rare risks of thrombosis and side effects.

Here are the latest figures for complications from AstraZeneca’s vaccineFive new cases of atypical thrombosis (clots), associated with AstraZeneca’s Covid-19 vaccine, were recorded in France between the 9th and 15th April, but none caused new deaths, according to health authorities.

While this vaccine has been reserved since March 19 for people aged 55 and over, due to this adverse effect, these 5 new cases of these atypical thromboses have occurred in patients with an average age of 63 years, according to the weekly follow-up report from the French Medicines Agency (ANSM).

Since the start of vaccination, out of 3.2 million injections performed with AstraZeneca, the results are now 27 cases of thrombosis, including 8 deaths. This, therefore, makes one death for 400,000 injections, figures much lower than the risk of thrombosis when taking a plane, Olivier Véran recalled Thursday.

As many men as women

“The typology of reported cases remains identical to that of the last assessment, with a higher average age (median at 60 years), a sex ratio close to 1 (13 women / 14 men) and a location of thromboses mainly in the digestive level over the period, ”said the ANSM.

Due to the rare cases of thrombosis spotted in Europe and France, since March 19, the AstraZeneca vaccine is no longer administered to those under 55 years of age. For this category of people who have already received a dose of this vaccine, the High Authority for Health has recommended a second dose with Pfizer or Moderna.

A scientific committee dedicated to rare and atypical thrombosis observed after vaccinations against Covid-19 was set up this week by the ANSM to help clarify the mechanisms. This committee of specialists (infectious disease specialists, virologists, immunologists, epidemiologists, etc.), which also includes a representative of patient associations, will cover all the vaccines used against Covid-19.

Leave a Reply

Your e-mail address will not be published. Required fields are marked *